Pharmacokinetics/pharmacodynamics of antibacterials in the Intensive Care Unit: setting appropriate dosing regimens

International Journal of Antimicrobial Agents
Francesco Scaglione, Luca Paraboni

Abstract

Patients admitted to Intensive Care Units (ICUs) are at very high risk of developing severe nosocomial infections. Consequently, antimicrobials are among the most important and commonly prescribed drugs in the management of these patients. Critically ill patients in ICUs include representatives of all age groups with a range of organ dysfunction related to severe acute illness that may complicate long-term illness. The range of organ dysfunction, together with drug interactions and other therapeutic interventions (e.g. haemodynamically active drugs and continuous renal replacement therapies), may strongly impact on antimicrobial pharmacokinetics in critically ill patients. In the last decade, it has become apparent that the intrinsic pharmacokinetic (PK) and pharmacodynamic (PD) properties are the major determinants of in vivo efficacy of antimicrobial agents. PK/PD parameters are essential in facilitating the translation of microbiological activity into clinical situations, ensuring a successful outcome. In this review, we analyse the typical patterns of antimicrobial activity and the corresponding PK/PD parameters, with a special focus on a PK/PD dosing approach of the antimicrobial agent classes commonly utilised in the ICU ...Continue Reading

References

Sep 1, 1992·The Journal of Antimicrobial Chemotherapy·M el TounyM S Sabbour
Jul 1, 1991·The Journal of Antimicrobial Chemotherapy·M el TounyM S Sabbour
Jan 1, 1991·Fundamental & Clinical Pharmacology·L HaryM Andrejak
May 1, 1991·The Journal of Antimicrobial Chemotherapy·M E De BroeG A Verpooten
May 1, 1991·The Journal of Antimicrobial Chemotherapy·G BeaucaireM Caillaux
Jan 1, 1991·Antimicrobial Agents and Chemotherapy·L V FriedrichD Yarbrough
Jan 1, 1991·The Journal of Burn Care & Rehabilitation·D E ZaskeR G Strate
Mar 1, 1990·Clinical Pharmacokinetics·M Rowland
Jan 1, 1990·Intensive Care Medicine·C TriginerA Net
May 1, 1990·Antimicrobial Agents and Chemotherapy·M J RybakC K Svensson
Jan 1, 1989·European Journal of Clinical Pharmacology·L HaryJ P Capron
Jan 1, 1988·European Journal of Clinical Pharmacology·R A WalstadE Thurmann-Nielsen
Oct 1, 1984·The American Journal of Medicine·R D MooreP S Lietman
Nov 1, 1984·Antimicrobial Agents and Chemotherapy·C I BustamanteH C Standiford
Jan 1, 1984·Journal of Clinical Pharmacology·R SamplinerP Finley
Mar 1, 1983·The Journal of Antimicrobial Chemotherapy·D J MerrikinG N Rolinson
Mar 1, 1980·The American Journal of Medicine·B E KregerW R McCabe
Jul 1, 1995·Clinical Pharmacokinetics·U Jaehde, F Sörgel
May 1, 1995·Clinical Pharmacokinetics·B VrhovacF Plavsic
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·D P NicolauR Quintiliani
Aug 1, 1994·The Journal of Antimicrobial Chemotherapy·F M MacKenzieD Jason
May 1, 1993·Antimicrobial Agents and Chemotherapy·A ForrestJ J Schentag
Oct 1, 1995·Journal of Clinical Pharmacy and Therapeutics·C L Ronchera-OmsN V Jiménez
Mar 1, 1996·The Pediatric Infectious Disease Journal·W A Craig, D Andes
Jun 1, 1997·The Journal of Antimicrobial Chemotherapy·C D FreemanC H Nightingale
Feb 25, 1998·Clinical Pharmacokinetics·B M PowerK F Ilett
Apr 9, 1998·The Annals of Pharmacotherapy·M S JoyB J Zarowitz
Jul 24, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J D Turnidge
Dec 10, 1998·Journal of Internal Medicine·L LeiboviciS D Pitlik

❮ Previous
Next ❯

Citations

Feb 5, 2010·Intensive Care Medicine·Alexander D CornetNicole P Juffermans
Mar 1, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A CanutA R Gascón
Feb 25, 2010·Current Opinion in Infectious Diseases·Irja Lutsar, Tuuli Metsvaht
Mar 14, 2013·Shock·Rodrigo Spineli MacedoGuilherme Henrique Campos Furtado
Sep 14, 2011·Antimicrobial Agents and Chemotherapy·Takehito YamamotoHiroshi Suzuki
Aug 18, 2012·Annals of Intensive Care·Mohd H Abdul-AzizJason A Roberts
Jul 3, 2010·Critical Care : the Official Journal of the Critical Care Forum·Fabio Silvio TacconeFrédérique Jacobs
Jun 10, 2010·Clinical Pharmacokinetics·Antonello Di PaoloMario Del Tacca
Jul 12, 2011·Clinical Pharmacokinetics·Friederike TraunmüllerChristian Joukhadar
Dec 3, 2014·Emergency Medicine Clinics of North America·Robert S Green, Sean K Gorman
Nov 17, 2015·Expert Review of Anti-infective Therapy·Emilio MasedaLorenzo Aguilar
Apr 15, 2016·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Mohamed HishamGanesh Veerasekar
May 10, 2012·Journal of Pharmaceutical Sciences·Takehito YamamotoHiroshi Suzuki
Sep 26, 2012·Enfermedades infecciosas y microbiología clínica·Santiago GrauUNKNOWN VINCat Antimicrobial Group
Jul 16, 2011·The Veterinary Clinics of North America. Small Animal Practice·Eileen S Hackett, Daniel L Gustafson
Dec 16, 2009·International Journal of Antimicrobial Agents·Francesco Scaglione
Oct 2, 2009·Médecine et maladies infectieuses·D CommandeurI Drouillard
Jan 13, 2011·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Thomas P Lodise, Jill Butterfield
Sep 19, 2015·Therapeutic Drug Monitoring·Claudine ReiberNatascia Corti
May 6, 2015·Journal of Burn Care & Research : Official Publication of the American Burn Association·Amanda N SteeleNam K Tran
Feb 11, 2015·International Journal of Clinical Pharmacy·Barbara O M ClausJohan Decruyenaere
Jul 16, 2013·Enfermedades infecciosas y microbiología clínica·Andrés Canut BlascoAlicia Rodríguez-Gascón
Jun 28, 2016·International Journal of Antimicrobial Agents·Kritsana KongthavonsakulPeninnah Oberdorfer
May 16, 2015·Journal of Chemotherapy·Sungmin KiemJong-Lyul Ghim
Jul 16, 2016·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·O AsuphonP Sonthisombat
Jan 12, 2010·Journal of Burn Care & Research : Official Publication of the American Burn Association·M-J HallamB S Dheansa
Oct 24, 2018·Surgical Infections·Gary E SteinDaniel H Havlichek
Feb 28, 2015·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Anish Kumar, Narinder Pal Singh
Sep 21, 2010·British Journal of Hospital Medicine·Robert G Masterton, Craig Williams
Aug 30, 2019·The Journal of Trauma and Acute Care Surgery·Ruben D VillanuevaRyan Kennedy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

© 2022 Meta ULC. All rights reserved